CHALFONT ST. GILES, England--(BUSINESS WIRE)--GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher’s HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and diagnostics in its growing Life Sciences business.
Help employers find you! Check out all the jobs and post your resume.
